Search results for "Papillomavirus Vaccine"

showing 7 items of 37 documents

Potential impact of a nonavalent HPV vaccine on HPV related low-and high-grade cervical intraepithelial lesions: A referral hospital-based study in S…

2017

ABSTRACT While bivalent and quadrivalent HPV vaccines have been used for about 10 years, a nonavalent vaccine against HPV types 6/11/16/18/31/33/45/52 and 58 has been recently approved by FDA and EMA and is now commercially available. The objective of our study was to evaluate the potential impact of the nonavalent vaccine on HPV infection and related low- and high-grade squamous intraepithelial lesions (LSIL, HSIL), compared to the impact of the quadrivalent vaccine, in a female population living in Sicily (Italy). Low estimates of HPV vaccine impact were calculated as prevalence of HPV 6/11/16/18/31/33/45/52 and 58 genotypes, alone or in association, but excluding presence of other HPV ty…

OncologyAdultmedicine.medical_specialtyReferralGenotypeImmunologyUterine Cervical NeoplasmsHPV vaccinesCervix UteriHospital based study03 medical and health sciences0302 clinical medicineHuman Papillomavirus Recombinant Vaccine Quadrivalent Types 6 11 16 18Internal medicinevaccineGenotypemedicinePrevalenceHumansImmunology and Allergy030212 general & internal medicinePapillomavirus VaccinesquadrivalentReferral and ConsultationSicilyFemale populationsquamous intraepithelial lesionGynecologyPharmacologyPotential impactHpv typesbusiness.industryPapillomavirus InfectionsHPV infectionsquamous intraepithelial lesionsvirus diseasesmedicine.diseaseUterine Cervical DysplasiaResearch Papersimpact estimateHPV infection; impact estimate; nonavalent; quadrivalent; squamous intraepithelial lesions; vaccine; Immunology and Allergy; Immunology; Pharmacology030220 oncology & carcinogenesisHPV infectionFemalebusinessnonavalent
researchProduct

Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study.

2010

Summary Background Knowledge about the distribution of human papillomavirus (HPV) genotypes in invasive cervical cancer is crucial to guide the introduction of prophylactic vaccines. We aimed to provide novel and comprehensive data about the worldwide genotype distribution in patients with invasive cervical cancer. Methods Paraffin-embedded samples of histologically confirmed cases of invasive cervical cancer were collected from 38 countries in Europe, North America, central South America, Africa, Asia, and Oceania. Inclusion criteria were a pathological confirmation of a primary invasive cervical cancer of epithelial origin in the tissue sample selected for analysis of HPV DNA, and informa…

OncologyInternational CooperationUterine Cervical NeoplasmsPolymerase Chain ReactionHuman papillomaviruses ; cervical cancer0302 clinical medicineGenotypeMass ScreeningYoung adult10. No inequalityPapillomaviridaeCervical cancerAged 80 and over0303 health sciencesParaffin Embeddingmedicine.diagnostic_testAge FactorsMiddle Aged3. Good healthOncology030220 oncology & carcinogenesisCarcinoma Squamous CellFemaleAdultmedicine.medical_specialtyAdolescentGenotypeHPV vaccinesAdenocarcinoma03 medical and health sciencesCarcinoma AdenosquamousYoung AdultInternal medicinemedicineHumansNeoplasm InvasivenessGenetic TestingPapillomavirus VaccinesGenotyping030304 developmental biologyGenetic testingAgedRetrospective StudiesGynecologybusiness.industryPapillomavirus InfectionsBasic Medical Sciencesmedicine.diseaseCross-Sectional StudiesLogistic ModelsBIOMEDICINE AND HEALTHCAREDNA ViralLinear Array HPV Genotyping TestLinear ModelsCervarixbusinessThe Lancet. Oncology
researchProduct

Controversies surrounding human papilloma virus infection, head & neck vs oral cancer, implications for prophylaxis and treatment.

2009

Head & Neck Cancer (HNC) represents the sixth most common malignancy worldwide and it is historically linked to well-known behavioural risk factors, i.e., tobacco smoking and/or the alcohol consumption. Recently, substantial evidence has been mounting that Human Papillomavirus (HPV) infection is playing an increasing important role in oral cancer. Because of the attention and clamor surrounding oral HPV infection and related cancers, as well as the use of HPV prophylactic vaccines, in this invited perspective the authors raise some questions and review some controversial issues on HPV infection and its role in HNC, with a particular focus on oral squamous cell carcinoma. The problematic def…

Oncologymedicine.medical_specialtyPathologyMalignancyPapillomavirus VaccinesInternal medicineHumansMedicineHuman papilloma virus infectionHPV infection;oral cancer;Papillomavirus VaccinesMouth neoplasmbusiness.industryTransmission (medicine)Papillomavirus InfectionsHPV infectionvirus diseasesCancerGenetic Therapyoral cancerPrognosismedicine.diseaseCombined Modality Therapyfemale genital diseases and pregnancy complicationsstomatognathic diseasesOncologyOtorhinolaryngologyOtorhinolaryngologyHead and Neck NeoplasmsHPV infectionCommentaryMouth Neoplasmsbusiness
researchProduct

Knowledge, opinions and attitudes of Italian mothers towards HPV vaccination and Pap test

2015

Aim This study evaluated the knowledge and attitudes of Italian mothers – whose daughters had been vaccinated in 2012 – towards primary (anti-HPV vaccination) and secondary (Pap test screening) cervical cancer prevention, as well as sources of information and mother-daughter communication on health issues. Methods The survey – part of a multicenter study carried out in 4 Italian cities (Ferrara, Rome, Cassino and Palermo) – was conducted through self-administered questionnaires. The first univariate analysis evaluated differences between mothers of under-18s and over-18s relative to knowledge and attitudes on HPV vaccination and Pap test. The second univariate analysis evaluated differences…

QuestionnairesUterine Cervical NeoplasmHealth Knowledge Attitudes PracticeCancer ResearchUterine Cervical NeoplasmsSurveys and QuestionnairesSurveys and QuestionnaireChildPapillomavirus VaccineCervical cancerUnivariate analysisPracticeMothermedicine.diagnostic_testHealth KnowledgeMedicine (all)VaccinationHpv vaccinationGeneral MedicineMiddle AgedVaccinationPap-testItalyOncologyFemaleHumanPapanicolaou TestAdultmedicine.medical_specialtyHuman papillomavirusAdolescentPublic health interventionsSocio-culturaleMothersJudgmentmedicineSexually transmitted infectionsHumansPap testPapillomavirus VaccinesAdolescent; Adult; Child; Female; Humans; Italy; Judgment; Middle Aged; Papanicolaou Test; Papillomavirus Infections; Papillomavirus Vaccines; Self Report; Surveys and Questionnaires; Uterine Cervical Neoplasms; Health Knowledge Attitudes Practice; VaccinationPapillomavirus InfectionSettore MED/42 - IGIENE GENERALE E APPLICATAGynecologySexually transmitted infectionbusiness.industryhuman papillomavirus; mothers; pap-test; sexually transmitted infections; vaccinationPapillomavirus InfectionsHuman papillomavirus; Mothers; Pap-test; Sexually transmitted infections; Vaccination; Adolescent; Adult; Child; Female; Humans; Italy; Judgment; Middle Aged; Papanicolaou Test; Papillomavirus Infections; Papillomavirus Vaccines; Questionnaires; Self Report; Uterine Cervical Neoplasms; Health Knowledge Attitudes Practice; Vaccination; Cancer Research; Oncology; Medicine (all)medicine.diseaseHuman papillomavirus; Mothers; Pap-test; Sexually transmitted infections; Vaccination; Adolescent; Adult; Child; Female; Humans; Italy; Judgment; Middle Aged; Papanicolaou Test; Papillomavirus Infections; Papillomavirus Vaccines; Self Report; Surveys and Questionnaires; Uterine Cervical Neoplasms; Health Knowledge Attitudes Practice; Vaccination; Cancer Research; Oncology; Medicine (all)Sexual intercourseHuman papillomaviruMulticenter studyFamily medicineAttitudesSelf Reportbusiness
researchProduct

Spontaneous Regression of a Recalcitrant Wart after Bivalent Papillomavirus Vaccination

2017

business.industryCross ProtectionPapillomavirus InfectionsRemission SpontaneousVirologyBivalent (genetics)Vaccination030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicine030220 oncology & carcinogenesisPediatrics Perinatology and Child HealthHumansMedicineFemalePapillomavirus VaccinesWartsHuman papillomavirusChildbusinessPapillomaviridaeThe Journal of Pediatrics
researchProduct

Knowledge about infection with human papillomavirus: a systematic review.

2007

Abstract Objective. Human papillomavirus (HPV) is a necessary cause of cervical cancer and genital warts. The aim of this systematic literature review was to provide an overview of knowledge about HPV infection among the public, students, patients and health professionals. Method. PubMed searches were performed and the results of studies were reported by age, gender, study population, country, recruitment score and year of study conduct. The recruitment score covered the mode of recruitment, study size and response rate. Results. We included 39 studies published between 1992 and 2006 covering a total of 19,986 participants. The proportion of participants who had heard of HPV varied from 13%…

medicine.medical_specialtyHealth Knowledge Attitudes PracticeEpidemiologyPopulationUterine Cervical NeoplasmsGenital wartsmedicineHumansPapillomavirus VaccinesRisk factoreducationPapillomaviridaeGynecologyCervical cancerResponse rate (survey)education.field_of_studybusiness.industryPapillomavirus InfectionsPublic Health Environmental and Occupational HealthHPV infectionvirus diseasesmedicine.diseaseSystematic reviewCondylomata AcuminataFamily medicinePopulation studyFemalebusinessPreventive medicine
researchProduct

[Adverse reactions to human papillomavirus vaccine in the Valencian Community (2007-2011)].

2014

Introduction: In 2009, two cases of seizures in adolescents following quadrivalent human papillomavirus vaccine (qHPV) administration generated important media attention, and adversely affected public trust in this vaccine. Our objectives were to describe suspected adverse reactions (SARs) reported to the Pharmacovigilance Centre in the Valencian Community (PCVC) after administration of HPV vaccine, and to compare reporting rates of syncope and seizures following this vaccine with those of other vaccines administered to girls aged 13–15 years. Materials and methods: Descriptive study of SARs reported following administration of this vaccine to the PCVC between 2007 and 2011. Results: The cl…

medicine.medical_specialtyPediatricsHuman papillomavirusTime FactorsAdolescentVirus del papiloma humanoVaccines AdministeredHuman papillomavirus vaccinePediatricsRJ1-570Valencian communitySyncopeReporting ratePharmacovigilanceHuman Papillomavirus Recombinant Vaccine Quadrivalent Types 6 11 16 18SeizuresManagement of Technology and InnovationPharmacovigilanceMedicineHumansRetrospective StudiesbiologyVacunabusiness.industryReacción adversaSyncope (genus)PharmacovigitanceTasa de notificaciónbiology.organism_classificationSurgeryVaccinationFarmacovigilanciaSpainFemalebusinessAdverse reactionsVaccineAnales de pediatria (Barcelona, Spain : 2003)
researchProduct